The Future of Pharmacogenomics: A Collaboration Between Pharmacy and Medical Laboratories

Authors

  • Salem Kraidem Mohsen Alharbi,Abdul Rahman Marouf,Ibtesam Khaled Alattas, Manal Mahmoud Abulaban,Ali Hudlan Ibrahim Alaryani
  • Abid Abdullah Altayari,Saleh Mrdi Khudhari Alghamdi,Fawaz Ahmed Jarallh Alzahrani,Eshraq Abdulhadi Alghamdi,Fatimah Hasan Ahmad Ageel

DOI:

https://doi.org/10.63278/jicrcr.vi.2360

Abstract

Pharmacogenomics, a dynamic field at the intersection of pharmacology and genomics, is transforming healthcare by enabling personalized medicine. This multidisciplinary approach leverages genetic insights to optimize drug efficacy, minimize adverse effects, and enhance patient care. Key advancements in genomic research, next-generation sequencing, and bioinformatics have propelled pharmacogenomics into clinical practice. Central to its success is the collaboration between pharmacy and medical laboratories, which integrates expertise in drug metabolism and genetic testing to personalize treatment regimens. Despite challenges such as high costs, ethical concerns, and integration barriers, pharmacogenomics holds immense promise. This paper explores the scientific and technological foundations, interdisciplinary collaboration, and future directions in pharmacogenomics, underscoring its potential to revolutionize medicine and improve patient outcomes.

Downloads

Published

2024-06-12

How to Cite

Salem Kraidem Mohsen Alharbi,Abdul Rahman Marouf,Ibtesam Khaled Alattas, Manal Mahmoud Abulaban,Ali Hudlan Ibrahim Alaryani, & Abid Abdullah Altayari,Saleh Mrdi Khudhari Alghamdi,Fawaz Ahmed Jarallh Alzahrani,Eshraq Abdulhadi Alghamdi,Fatimah Hasan Ahmad Ageel. (2024). The Future of Pharmacogenomics: A Collaboration Between Pharmacy and Medical Laboratories. Journal of International Crisis and Risk Communication Research , 1806–1814. https://doi.org/10.63278/jicrcr.vi.2360

Issue

Section

Articles